New therapies for mature T-cell leukaemia?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1315, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal daunorubicin + cytarabarine valid for leukaemia?

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Double-unit UCBT best for acute leukaemia?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 646, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cytarabine/etoposide/ibritumomab tiuxetan Y-90: Treatment-related acute myeloid leukaemia?: case report

Reactions Weekly, Vol. 1, Iss. 1295, 2010-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Corticosteroids/mycophenolate mofetil/tacrolimus: Atypical acute leukaemia?: case report

Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

TNF- inhibitors: `new era' of biological therapies for RA?

Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite